Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: " Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease" [NA]
Completed clinical trial evaluating Art Therapy for symptomatic relief in patients with cancer undergoing therapy; results posted.
-
EMA approval · 2026-08-25EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd
The EMA authorised Akynzeo (netupitant and palonosetron hydrochloride) for vomiting, nausea, cancer-related indications.
-
EMA approval · 2026-08-20EMA Authorised: Instanyl (Fentanyl citrate) — Istituto Gentili S.r.l.
EU authorization for Instanyl (fentanyl citrate) by Istituto Gentili S.r.l. for pain and cancer-related indications.
-
EMA approval · 2026-08-19EMA Authorised: Nivestim (filgrastim) — Pfizer Europe MA EEIG
Nivestim (filgrastim) has been authorised by EMA for hematopoietic stem cell transplantation and cancer indications.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: Positive Activities for Asian American Cancer Patients and Caregivers [NA]
A completed clinical trial investigating positive activities for Asian American cancer patients and caregivers; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Engaging and Activating Cancer Survivors in Genetic Services Study [NA]
Results from a completed study evaluating engagement and activation of cancer survivors in genetic services.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: The PediQUEST Response Intervention Study [NA]
Clinical trial results report completed study on the PediQUEST Response Intervention for patients with advanced cancer.
-
EMA approval · 2026-08-04EMA Authorised: Silapo (epoetin zeta) — Stada Arzneimittel AG
The EMA authorises Silapo (epoetin zeta) by Stada Arzneimittel AG for treating anemia associated with cancer, chronic kidney failure, and bl…
-
EMA approval · 2026-07-29EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH
PecFent (fentanyl) by Gruenenthal GmbH has been authorised for use in pain and cancer indications in the EU.
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: Treating Pain in Children With Cancer: Pain Buddy [NA]
Clinical trial results for Pain Buddy assessing pain treatment in pediatric cancer patients have been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
EMA approval · 2026-07-20EMA Authorised: Retacrit (epoetin zeta) — Pfizer Europe MA EEIG
Authorised status for Retacrit (epoetin zeta) by EMA for use in anemia-related indications, including kidney failure, cancer-related anemia,…
-
EMA approval · 2026-07-15EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH
EMA authorizes PecFent (fentanyl) by Gruenenthal GmbH for pain and cancer indications.
-
EMA approval · 2026-07-15EMA Authorised: Rozlytrek (Entrectinib) — Roche Registration GmbH
The EMA authorises Rozlytrek (entrectinib) for cancer, including non-small cell lung carcinoma, under conditional approval.
-
EMA approval · 2026-07-14EMA Authorised: Dyrupeg (pegfilgrastim) — CuraTeQ Biologics (Malta) Limited
Dyrupeg (pegfilgrastim) has been authorised by the EMA for neutropenia and cancer indications.
-
EMA approval · 2026-07-14EMA Authorised: Zefylti (filgrastim) — CuraTeQ Biologics (Malta) Limited
Zefylti (filgrastim) has been authorised by EMA for use in neutropenia, hematopoietic stem cell transplantation, and cancer indications.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: MOST EMPOWER: Optimizing An Emotion Regulation Intervention [NA]
A completed clinical trial evaluating an emotion regulation intervention (MOST EMPOWER) for cancer patients; results posted.
-
EMA approval · 2026-07-03EMA Authorised: NeoRecormon (epoetin beta) — Roche Registration GmbH
NeoRecormon (epoetin beta) has been authorised by the EMA for related indications in chronic kidney failure, anemia, cancer, and autologous …
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) [NA]
Clinical trial results evaluating COVID-19 infection screening in cancer patients have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: Thromboembolic Risk Screening in Patients With Cancer and COVID-19 [NA]
A completed clinical trial evaluating thromboembolic risk screening in patients with cancer and COVID-19; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Information Consultation by Radiotherapy Manipulator [NA]
Completed clinical trial results for a cancer study 'Information Consultation by Radiotherapy Manipulator' (NCT02867462) with results posted…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Education About Health and Cancer Study [NA]
Clinical trial results for an education study related to health and cancer have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab [EARLY_Phase 1]
Early phase 1 study evaluating decompressive spine radiosurgery combined with pembrolizumab in patients with epidural spinal tumors and canc…
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Educational Video for Genetic Testing [NA]
Completed clinical trial evaluating an educational video for genetic testing; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Helping Improve Pediatric Patient Outcomes [NA]
A completed clinical trial results report from Kaiser Permanente focusing on pediatric cancer and animal-assisted activities, with results p…